About Nym
Nym is a company based in New York (United States) founded in 2017. It operates as a AI-as-a-Service. Nym has raised $94.5 million across 4 funding rounds from investors including Bessemer Venture Partners, Lightspeed Venture Partners and PSG Equity. Nym offers products and services including Autonomous Medical Coding Engine. Nym operates in a competitive market with competitors including R1 RCM, LOGEX, AKASA, RateGain and XSOLIS, among others.
- Headquarter New York, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nym Health Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$94.5 M (USD)
in 4 rounds
-
Latest Funding Round
$47 M (USD), Series C
Oct 01, 2024
-
Investors
Bessemer Venture Partners
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nym
Nym offers a comprehensive portfolio of products and services, including Autonomous Medical Coding Engine.
Medical coding is automated with high accuracy levels.
People of Nym
Unlock access to complete
Funding Insights of Nym
Nym has successfully raised a total of $94.5M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $47 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nym
Nym has secured backing from 10 investors, including venture fund and angel investors. Prominent investors backing the company include Bessemer Venture Partners, Lightspeed Venture Partners and PSG Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital and operational support are provided to growth-stage software companies.
|
Locked | Locked | Locked | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Investments are made in early and growth-stage technology startups.
|
Locked | Locked | Locked |
Investor details for Nym
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nym
Investment portfolio details for Nym
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nym
Detailed financials for Nym
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nym Comparisons
Peer comparison for Nym
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nym
Nym operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as R1 RCM, LOGEX, AKASA, RateGain and XSOLIS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
End-to-end revenue cycle management is provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Healthcare financial management solutions are developed for institutions and physicians.
|
|
| Locked | Locked | Locked |
Revenue cycle automation platforms are provided for healthcare reimbursement.
|
|
| Locked | Locked | Locked |
SaaS solutions for hospitality revenue and operations management are delivered.
|
|
| Locked | Locked | Locked |
AI-based platform for physicians and payers to analyze denial management
|
|
| Locked | Locked | Locked |
SaaS revenue management solutions are offered to airlines for optimization.
|
Detailed competitors of Nym
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nym
Complete news archive for Nym
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nym
Nym was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Nym is headquartered in New York, United States. It is registered at New York, New York, United States.
Or Peles is the current CEO of Nym.
Nym is a funded company, having raised a total of $94.5M across 4 funding rounds to date.
Nym is engaged in providing autonomous medical coding solutions for health systems and physician groups. The company operates within the healthcare technology sector, offering a specialized engine that deciphers clinical language in patient charts to assign medical codes with high accuracy. Solutions are designed to reduce coding costs, accelerate billing processes, and improve revenue capture while supporting medical coding teams. Implementation of innovative Clinical Language Understanding (CLU) technology ensures over 95 percent accuracy and transparent audit trails.
Nym offers Autonomous Medical Coding Engine.
Nym has 10 investors. Key investors include Bessemer Venture Partners, Lightspeed Venture Partners, PSG Equity, Google Ventures, and Addition.